MedReleaf is a high-quality name in the cannabis space. We see the likelihood of a transaction between Aurora and MedReleaf high after both companies confirmed they are in talks. We think Aurora could pay a premium of 40% – 60% for MedReleaf, with a small cash portion in a mostly stock deal. Read More
The post Why Would MedReleaf Sell To Aurora Now? appeared first on Dagga Magazine.